FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For
the
Month of August, 2007
Commission
File Number 1-32001
(Translation
of registrant’s name into English)
2
Meridian Road, Toronto, Ontario M9W 4Z7
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form
20-F x Form
40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1): ____
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form
6-K
if submitted solely to provide an attached annual report to security
holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): ____
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper
of a
Form 6-K if submitted to furnish a report or other document that the registrant
foreign private issuer must furnish and make public under the laws of the
jurisdiction in which the registrant is incorporated, domiciled or legally
organized (the registrant’s “home country”), or under the rules of the home
country exchange on which the registrant’s securities are traded, as long as the
report or other document is not a press release, is not required to be and
has
not been distributed to the registrant’s security holders, and, if discussing a
material event, has already been the subject of a Form 6-K submission or
other
Commission filing on EDGAR.
Indicate
by check mark whether the registrant by furnishing the information contained
in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
¨ No
x
If
“Yes” is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b):82-_______________.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
Lorus
Therapeutics Inc.
|
|
|
|
|
Date:
August 29, 2007
|
By:
|
/s/
“Elizabeth Williams” |
|
|
Elizabeth
Williams |
|
|
Director
of Finance |
EXHIBIT
INDEX
99.1
|
Annual
Financial Statements |
|
|
99.2
|
Management's
Discussion and Analysis |
|
|
99.3
|
Annual
Information Form |
|
|
99.4
|
Form
52-109F1 - Certifications of Annual
Filings |